Tools commonly used in the Organ & Tissue Banks industry for day-to-day tasks and operations.

• Preservation solutions
• Cryopreservation equipment
• Sterilization equipment
• Tissue processing equipment
• Microscopes
• Surgical instruments
• Blood typing kits
• DNA testing equipment
• Medical imaging equipment
• Organ transport containers

Common products and services typical of NAICS Code 621991-02, illustrating the main business activities and contributions to the market.

• Heart valves
• Corneas
• Skin grafts
• Bone grafts
• Tendons
• Ligaments
• Cartilage
• Veins
• Arteries
• Pancreas

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• American Association Of Tissue Banks (AATB) Accreditation: AATB is a non-profit organization that accredits tissue banks in the US. The accreditation ensures that the tissue bank meets the highest standards of quality and safety. The accreditation process includes an on-site inspection, review of policies and procedures, and evaluation of the tissue bank's quality system.
• Clinical Laboratory Improvement Amendments (CLIA) Certification: CLIA certification is required for all laboratories that perform testing on human specimens for the purpose of diagnosis, prevention, or treatment of disease. The certification ensures that the laboratory meets the quality standards set by the Centers for Medicare & Medicaid Services (CMS).
• Food and Drug Administration (FDA) Registration: FDA registration is required for all facilities that manufacture, process, pack, or store human cells, tissues, and cellular and tissue-based products (HCT/Ps). The registration ensures that the facility complies with the FDA regulations for HCT/Ps.
• State Tissue Bank License: A state tissue bank license is required for all tissue banks that operate in the US. The license ensures that the tissue bank complies with the state regulations for tissue banking. The requirements for the license vary by state.
• Occupational Safety and Health Administration (OSHA) Bloodborne Pathogens Standard: The OSHA Bloodborne Pathogens Standard requires employers to protect workers who are exposed to blood or other potentially infectious materials (OPIM) as part of their job duties. The standard includes requirements for training, personal protective equipment, and exposure control plans.

A concise historical narrative of NAICS Code 621991-02 covering global milestones and recent developments within the United States.

• The history of the Organ & Tissue Banks industry dates back to the early 20th century when the first successful kidney transplant was performed in 1954. This breakthrough led to the establishment of the first organ bank in the United States in 1958. The industry continued to grow, and in 1984, the National Organ Transplant Act was passed, which established the Organ Procurement and Transplantation Network (OPTN) to manage organ allocation and distribution. In recent years, the industry has seen significant advancements in technology, including the development of 3D printing for organ and tissue engineering, and the use of stem cells for regenerative medicine. Additionally, there has been a growing trend towards living organ donation, which has increased the number of available organs for transplant.

The anticipated future trajectory of the NAICS 621991-02 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the Organ & Tissue Banks industry in the USA is positive. The demand for organ and tissue transplants is expected to increase due to the aging population and the rise in chronic diseases. Additionally, advancements in medical technology and research are expected to improve the success rates of transplants and increase the number of viable organs and tissues available for transplant. However, the industry may face challenges such as regulatory changes and funding issues. Overall, the industry is expected to experience steady growth in the coming years.

Recent groundbreaking advancements and milestones in the Organ & Tissue Banks industry, reflecting notable innovations that have reshaped its landscape.

• Development Of 3D Printing Technology for Organ and Tissue Transplantation: 3D printing technology has been used to create artificial organs and tissues that can be used for transplantation. This technology has the potential to revolutionize the industry by reducing the need for organ donors and increasing the success rates of transplants.
• Increased Use Of Regenerative Medicine: Regenerative medicine involves the use of stem cells and other techniques to repair and regenerate damaged tissues and organs. This approach has the potential to reduce the need for organ donors and increase the success rates of transplants.
• Advancements In Immunosuppressive Drugs: Immunosuppressive drugs are used to prevent the body from rejecting transplanted organs and tissues. Recent advancements in these drugs have improved their effectiveness and reduced their side effects, making them a more viable option for transplant patients.
• Expansion Of Organ and Tissue Donor Registries: Organ and tissue donor registries have been established to increase the number of available organs and tissues for transplant. Recent efforts to expand these registries have been successful in increasing the number of donors and improving the success rates of transplants.
• Use Of Artificial Intelligence In Organ Allocation: Artificial intelligence has been used to develop algorithms that can match organs with potential recipients more effectively. This approach has the potential to reduce wait times for transplants and improve the success rates of transplants.